Quantcast

Latest cardiac dysrhythmia Stories

2014-09-19 23:01:32

Defendant Xarelto manufacturers want several lawsuits dismissed from Pennsylvania state court, arguing that there is no connection with the state. Rockville Centre, NY (PRWEB) September 19, 2014 According to a report from HarrisMartin dated September 17, the manufacturers of the embattled blood-thinner Xarelto, named as defendants in several lawsuits filed in the Philadelphia County Court of Common Pleas, have moved the court to dismiss those suits because the alleged circumstances of the...

2014-09-09 08:32:09

First FDA-Cleared Mobile ECG Device to be offered in India - Provides Physicians an Instant Screening Tool for Arrhythmias, Major Step in Cardiac Care HYDERABAD, India and SAN FRANCISCO, Sept. 9, 2014 /PRNewswire/ -- Apollo Hospitals and AliveCor, Inc. announced today the launch of an exclusive collaboration agreement. Apollo Hospitals and AliveCor are joining forces to tackle the growing problem of heart arrhythmias, by providing an innovative mobile device to improve access to...

2014-09-04 23:01:58

The results of a recently-concluded study purport to show that Xarelto (rivaroxaban) is as safe as warfarin for patients atrial fibrillation patients awaiting elective cardioversion, even though four persons included in the study died. Rockville Centre, NY (PRWEB) September 04, 2014 According to an article published on September 2 at medpagetoday.com, atrial fibrillation patients awaiting elective cardioversion who had their oral anticoagulant switched from warfarin to Xarelto “were...

2014-09-02 12:29:39

BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- -- GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients at risk of stroke in everyday clinical practice -- Data from nearly 12,500 patients enrolled in the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent academic research initiative, have illustrated that stroke prevention strategies for atrial...

2014-09-02 12:29:29

BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- Registry provides new insights into AF treatment decisions, including patients' quality of life and treatment satisfaction[1],[2] (Photo: http://photos.prnewswire.com/prnh/20140902/703596 ) ESC Congress 2014, 02 September 2014, Barcelona, Spain: Daiichi Sankyo today announced one year results of the PREvention oF thromboembolic events-European Registry in Atrial Fibrillation (PREFER...

2014-09-02 04:21:13

X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal BARCELONA, Spain, Sept. 2, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) and its development partner, Bayer HealthCare, announced today results from the X-VeRT trial, demonstrating once-daily XARELTO(®) (rivaroxaban) may be an alternative to vitamin K antagonists (VKA) in treating and reducing the risk of blood clots in non-valvular atrial...

2014-08-31 08:21:14

- Findings show risk of bleeding, along with overall efficacy(1), consistently ranked among top considerations for cardiologists when choosing a treatment to reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) BARCELONA, Spain, Aug. 31, 2014 /PRNewswire/ -- Daiichi Sankyo and the Heart Rhythm Society today announced results from a global survey, which polled cardiologists from around the world and revealed that a majority (58%) of cardiologists...

2014-08-27 23:05:43

Transparency Market Research has published a new report titled "Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report database. Albany, New York (PRWEB) August 27, 2014 According to a new market report published by Transparency Market Research "Ablation Technologies Market (Applications: Cardiovascular, Gynecology, Pain Management, Oncology, Urology, Ophthalmology; Technologies: Radiofrequency,...

2014-08-25 08:27:37

-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014 Hot Line Session RARITAN, N.J., Aug. 25, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today that results from the Phase 3b exploratory X-VeRT study, investigating the oral Factor Xa inhibitor XARELTO(®) (rivaroxaban) in patients with non-valvular atrial...

exercise
2014-08-23 03:00:49

American Heart Association Rapid Access Journal Report Increasing the amount or intensity of physical activity can cut the chances of older women developing a life-threatening irregular heartbeat, according to new research in the Journal of the American Heart Association (JAHA). Researchers found that post-menopausal women, enrolled in the Women’s Health Initiative, who were the most physically active had a 10 percent lower risk of developing atrial fibrillation (AF), compared to...


Latest cardiac dysrhythmia Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

Cardiopulmonary Resuscitation
2013-04-30 13:21:44

Cardiopulmonary resuscitation, commonly known as CPR, is an emergency procedure performed in an effort to preserve brain function and manually pump blood through to the body’s vital organs, until further measures are taken to restore spontaneous circulation. CPR is indicated in cardiac arrest patients, but may also be performed on patients with an unresponsive presentation or those experiencing agonal breaths or severe and prolonged arrhythmias such as bradycardia or tachycardia. The first...

Precordial Thump
2012-12-31 12:53:08

The precordial thump is an application of mechanical energy through a calculated strike to the torso when in a specific fatal heart rhythm. This procedure is used in very specific circumstances by highly trained health professionals with ACLS certifications. The Procedure While in the presence of a patient that is suffering a potentially fatal heart rhythm, a medical provider can strike a calculated point on the sternum to disrupt that rhythm. The energy transferred by the provider is...

More Articles (3 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related